HOME Top Market Reports Clinical Trial Management System Market by End-user (Pharmaceutical & Biotechnology, Medical Device Companies, CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Service) - Global Forecast to 2021

Clinical Trial Management System Market by End-user (Pharmaceutical & Biotechnology, Medical Device Companies, CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Service) - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: August 2016
Report Code: HIT 1686

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global clinical trial management system market is valued at an estimated USD 534.0 Million in 2016, and is projected to grow at a CAGR of 11.5% during the forecast period of 2016 to 2021. Factors such as increasing research and development expenditure of life science and clinical research industries, rising number of clinical trials, and increasing adoption of CTMS solutions are driving the growth of the global clinical trial management system market. On the other hand, factors such as lack of skilled professionals to operate advanced CTMS solutions and budget constraints of small- and medium-sized pharmaceutical and biotechnology companies and small CROs are restraining the growth of the global clinical trial management system market.

The Asia-Pacific region has become an attractive destination for companies offering CTMS software. The high growth in this regional segment can be attributed to a number of factors, such as rising number of clinical trials, presence of a large number of CROs, government initiatives, increase in outsourcing of clinical trials, availability of large and diverse patient population, presence of less stringent regulatory guidelines as compared to developed nations, and cost advantages offered by countries in the region.

Leading companies are outsourcing their clinical trials to the APAC region due the lower cost of the clinical trials in the region as compared to the developed regions (Europe and North America). For instance, The Federation of Indian Chambers of Commerce and Industry (FICCI) reported that clinical trials in India cost 40%–50% lesser as compared to developed countries, and ~10%–20% lesser as compared to other developing economies. It costs USD 14.8 million (INR 100 crore) in India as compared to USD 300-350 million abroad to conduct a clinical trial.

As of 2015, Oracle Corporation held the leadership position in the global clinical trial management system market. Other CTMS market players include Medidata Solutions, Inc. (U.S.), PAREXEL International Corporation (U.S.), BioClinica Inc. (U.S.), Bio-Optronics, Inc. (U.S.), ERT (U.S.), eClinforce (U.S.), Merge Healthcare Incorporated (U.S.), DATATRAK International Inc. (U.S.), Veeva Systems, Inc. (U.S.), DSG Inc. (U.S.), Forte Research Systems, Inc.  (U.S.), and MedNet Solutions, Inc. (U.S.).

Stakeholders

  • Healthcare IT service providers
  • eClinical solution vendors
  • Clinical research organizations
  • Pharmaceutical/biopharmaceutical companies
  • Research and development (R&D) companies
  • Business research and consulting service providers
  • Medical research laboratories
  • Academic medical centers/universities/hospitals

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This research report categorizes the clinical trial management system market into the following segments and subsegments:

Global CTMS Market, by End User

  • Pharmaceutical and Biopharmaceutical Companies
  • Contract Research Organizations
  • Medical Device Companie
  • Others

Global CTMS Market, by Delivery Mode

  • Web-based (Hosted) CTMS 
  • Licensed Enterprise (On-premise) CTMS  
  • Cloud-based (SaaS) CTMS

Global CTMS Market, by Type

  • Enterprise CTMS
  • Site CTMS

Global CTMS Market, by Component

  • Software
  • Services

Global CTMS Market, by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis:

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Geographic Analysis:

  • Further breakdown of the North American clinical trial management system market into the U.S. and Canada.
  • Further breakdown of the Rest of the World clinical trial management system market into Latin America, the Middle East, and Africa

Company Information:

  • Detailed analysis and profiling of additional market players (Up to 5)

Please click here to get the updated version of e-Clinical Trials Solutions/Suite/Technologies Market – (CTMS, CDMS, EDC, IVRS, ePRO & IRB Systems) Global Trends, Opportunities & Forecasts (2012 – 2017)

Table of content

1 Introduction

2 Research Methodology

3 Executive Summary
    3.1 Introduction
    3.2 Market, by End-user (2016)
    3.3 Market, by Delivery Mode, (2016) 
    3.4 Market Share, by Type, (2016)
    3.5 Market share, by Component, (2016) 
    3.6 Market, by Geography (2016)
    3.7 Competitive Landscape

4 Premium Insights

5 Market Overview
    5.1 Market Dynamics
           5.1.1 Drivers
                    5.1.1.1 Increasing research and development expenditure of life science and clinical research industry
                    5.1.1.2 Rising number of clinical trials
                    5.1.1.3 New product launches
                    5.1.1.4 Increasing customer base owing to adoption of CTMS solutions
    5.2 Restraints
           5.2.1 Lack of skilled professionals
           5.2.2 Budget constraints
    5.3 Opportunities
           5.3.1 Increasing outsourcing of clinical trials to CROs in Asian countries
           5.3.2 Use of platform-as-a-service (PaaS) platform and mobile computing
    5.4 Trends 
           5.4.1 Collaborative CTMS: integration of CTMS with other software such as HIS, EMR and EDC

6 Market By End-User
    6.1 Introduction 
    6.2 Clinical Research Organizations (CROS) 
           6.2.1 Rising outsourcing of clinical trials by pharma and biotechnology companies to CROs
    6.3 Pharmaceutical & biotech companies 
           6.3.1 Increasing R&D expenditure of pharmaceutical and biopharmaceutical companies
    6.4 Medical device companies
           6.4.1 Availability of government funding for development of innovative medical devices
    6.5 Others

7 Market By Delivery Mode 
    7.1 Introduction  
    7.2 Web-Based (Hosted) Clinical Trial Management System  
           7.2.1 Benefits provided by web-based solutions have been driving the market
    7.3 Licensed Enterprise (On Premise) Clinical Trial Management System  
    7.4 Cloud-Based (SaaS) Clinical Trial Management System  
           7.4.1 Increasing adoption of cloud-based solutions by various organizations in the life science industry

8 Market By Components 
    8.1 Introduction  
    8.2 Software  
    8.3 Services  

9 Market By Clinical Trial Management System Type 
    9.1 Introduction  
    9.2 Enterprise Clinical Trial Management System  
    9.3 Site Clinical Trial Management System  

10 Clinical Trial Management System Market, By Region
     10.1 overview
     10.2 North America
     10.3 Europe
     10.4 Asia-Pacific
     10.5 Rest of the World

11 Competitive Landscape
     11.1 Global CTMS Solutions Market Share, By Key Player, 2015
     11.2 Competitive Profile Matrix – Top three players
     11.3 Competitive Situation and Trends

12 Company Profiles
     12.1 ORACLE CORPORATION
     12.2 Medidata Solutions, Inc.
     12.3 PAREXEL International Corporation
     12.4 BioClinica, Inc. (BioClinica)
     12.5 Bio-Optronics, Inc.
     12.6 Merge Healthcare Incorporated (An IBM Company)
     12.7 DATATRAK International, Inc. 
     12.8 VEEVA SYSTEMS, INC.
     12.9 DSG Inc. (Document Solutions Group) 
     12.10 eClinForce, Inc. 
     12.11 ERT
     12.12 Forte Research Systems, Inc.

13 Appendix


List of Tables (34 Tables)

Table 1 Impact Analysis: Drivers
Table 2 Impact Analysis: Restraints
Table 3 CTMS Market Size, By End User, 2014-2021 (USD Million)
Table 4 CTMS Market Size for Pharma and Biopharma Industry, By Region, 2014-2021 (USD Million)
Table 5 Clinical Trial Management System Market Size for Contract Research Organizations (CRO), By Region, 2014-2021 (USD Million)
Table 6 Clinical Trial Management System Market Size for Medical Device Manufacturers, By Region, 2014-2021 (USD Million)
Table 7 Clinical Trial Management System Market Size for Others, By Region, 2014-2021 (USD Million)
Table 8 Global Clinical Trial Management System Market Size, By Mode of Delivery, 2014–2021 (USD Million)
Table 9 Web-hosted (On-demand) CTMS Market Size, By Geography, 2014–2021 (USD Million)
Table 10 Licensed Enterprise (On-premise) CTMS Market Size, By Geography, 2014–2021 (USD Million)
Table 11 Cloud-based (SaaS) Market Size, By Geography, 2014–2021 (USD Million)
Table 12 Global Market Size, By Component, 2014–2021 (USD Million)
Table 13 Software Market Size, By Geography, 2014–2021 (USD Million)
Table 14 Services Market Size, By Geography, 2014–2021 (USD Million)
Table 15 Global Market Size, By Type, 2014–2021 (USD Million)
Table 16 Enterprise Market Size, By Geography, 2014–2021 (USD Million)
Table 17 Site CTMS Market Size, By Geography, 2014–2021 (USD Million)
Table 18 Clinical Trial Management System Market Size, By Geography, 2014–2021 (USD Million)
Table 19 North America: Market, By End-user, 2016-2021 (USD Million)
Table 20 North America: Market, By Type, 2016-2021 (USD Million)
Table 21 North America: Market, By Delivery Mode, 2016-2021 (USD Million)
Table 22 North America: Market, By Component, 2016-2021 (USD Million)
Table 23 Europe: Market, By End-user, 2016-2021 (USD Million)
Table 24 Europe: Market, By Type, 2016-2021 (USD Million)
Table 25 Europe: Market, By Delivery Mode, 2016-2021 (USD Million)
Table 26 Europe: Market, By Component, 2016-2021 (USD Million)
Table 27 APAC: Market, By End-user, 2016-2021 (USD Million)
Table 28 APAC: Market, By Type, 2016-2021 (USD Million)
Table 29 APAC: Market, By Delivery Mode, 2016-2021 (USD Million)
Table 30 APAC: Market, By Component, 2016-2021 (USD Million)
Table 31 RoW: CTMS Market, by End-user, 2016-2021 (USD MILLION)
Table 32 RoW: CTMS Market, by Type, 2016-2021 (USD MILLION)
Table 33 RoW: CTMS Market, by Delivery Mode, 2016-2021 (USD MILLION)
Table 34 RoW: CTMS Market, by component, 2016-2021 (USD MILLION)


List of Figures (48 Figures)

Figure 1 CTMS Market Share, By End User, 2016
Figure 2 CTMS Market Share by End-user (2016-2021)
Figure 3 R&D Expenditure of Top 10 Pharmaceutical Companies, 2013 vs. 2014 (USD Million)
Figure 4 CTMS Market Share for Pharmaceutical & Biopharmaceutical Companies, by Region (2016)
Figure 5 CRO Services Cover the Entire Drug Development Spectrum
Figure 6 Strategic Alliances between CROS and Pharma Companies (2011-2015)
Figure 7 CTMS Market Share for Contract Research Organizations (CRO), By Region (2016)
Figure 8 CTMS Market Share for Medical Device Companies, By Region (2016)
Figure 9 CTMS Market Share for Other End Users, By Region (2016)
Figure 10 Global CTMS Market Size, By Mode of Delivery (2016)
Figure 11 Web-hosted (On-demand) Segment to Dominate the Global CTMS Solutions Market In 2016
Figure 12 Web-hosted (On-demand) CTMS Market Share, By Geography (2016)
Figure 13 Licensed Enterprise (On-premise) CTMS Market Share, By Geography (2016)
Figure 14 Cloud-based (SaaS) Market Share, By Geography (2016)
Figure 15 Global CTMS Market Size, By Component, 2016 Vs. 2021
Figure 16 Software Market Share, By Geography (2016)
Figure 17 Services Market Share, By Geography (2016)
Figure 18 Global CTMS Market Share, By Type, 2016 Vs. 2021
Figure 19 Enterprise CTMS Market Share, By Geography (2016)
Figure 20 Site CTMS Market Share, By Geography (2016)
Figure 21 CTMS Market, By Geography (2016)
Figure 22 TOTAL NUMBER OF ONGOING CLINICAL TRIALS, BY REGION (June 2016)
Figure 23 U.S.: Presence of High Number of Organizations from Demand Side Number of Biotechnology R&D Organizations, By State (2014)
Figure 24 North America: CTMS Market Share, By End-user (2016)
Figure 25 North America: CTMS Market Share, By Type (2016)
Figure 26 North America: CTMS Market Share, By Delivery Mode (2016)
Figure 27 North America: CTMS Market Share, By Component (2016)
Figure 28 Europe: pharmaceutical R&D expenditure, by country (2012-13), in terms of USD Million
Figure 29 Europe: CTMS Market Share, By End-user (2016)
Figure 30 Europe: CTMS Market Share, By Type (2016)
Figure 31 Europe: CTMS Market Share, By Delivery Mode (2016)
Figure 32 Europe: CTMS Market Share, By Component (2016)
Figure 33 APAC: CTMS Market Share, By End-user(2016)
Figure 34 APAC: CTMS Market Share, By Type (2016)
Figure 35 APAC: CTMS Market Share, By Delivery Mode (2016)
Figure 36 APAC: CTMS Market Share, By Component (2016)
Figure 37 Row: CTMS Market Share, By End-user (2016)
Figure 38 Row: CTMS Market Share, By Type (2016)
Figure 39 Row: CTMS Market Share, By Delivery Mode (2016)
Figure 40 Row: CTMS Market Share, By Component (2016)
Figure 41 Competitive Situation and Trends
Figure 42 Geographic Revenue Mix of the Leading Market Players
Figure 43 ORACLE CORPORATION: Company Snapshot
Figure 44 Medidata Solutions, Inc.: Company Snapshot
Figure 45 PAREXEL International Corporation: Company Snapshot
Figure 46 Merge Healthcare Incorporated: Company Snapshot
Figure 47 DATATRAK International, Inc.: Company Snapshot
Figure 48 Veeva Systems, Inc.: Company a Snapshot

The global clinical trial management system market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 Million by 2021. The growth in this market is primarily driven by factors such as the increasing adoption of CTMS solutions during clinical trials, growing number of clinical trials, and rising R&D expenditure of pharmaceutical and biopharmaceutical companies.

CTM helps to improve efficiency and reduce the overall cost of conducting clinical trials. It assists companies involved in clinical trial to plan, track, and manage clinical trials and their progress. Moreover, it ensures financial management of the overall clinical trials process.

Based on end users, the clinical trial management system market is categorized into pharmaceutical and biopharmaceutical companies, contract research organizations, medical device companies, and other end users. The pharmaceutical and biopharmaceutical companies segment is expected to account for the largest market share in 2016, primarily due to the increasing R&D expenditure of this segment.

On the basis of delivery mode, the global clinical trial management system market is segmented into web-based (on-demand), licensed enterprise (on-premise), and cloud-based (SaaS) segments. The web-based (on-demand) segment is expected to account for the largest market share in 2016, primarily due to benefits provided by the web-based CTMS solution.

On the basis of component, the CTMS market is segmented into software and services. The software segment is expected to account for the largest share of the global clinical trial management system market in 2016, and is also expected to grow at the highest CAGR during the forecast period. This high growth is mainly attributed to the high adoption of the CTMS solution among the end users.

North America is expected to account for the largest share of the market in 2016, followed by Europe. However, the Asia-Pacific market is projected to grow at the highest CAGR during the forecast period. Factors such as increasing outsourcing of clinical trials, availability of large and diverse patient population, presence of less stringent regulatory guidelines as compared to developed nations, and comparatively less cost of conducting clinical trials in APAC countries are stimulating the growth of the market in this region.

Oracle Corporation (U.S.), Medidata Solutions, Inc. (U.S.), and PAREXEL International Corporation (U.S.) were the top players in the CTMS market in 2015. Leading players in the clinical trial management system market primarily adopted the strategies of new product launches and partnerships, agreements, and collaborations to strengthen their product portfolios, expand their customer base, and penetrate into high-growth markets.

Clinical Trial Management Systems Market, CTMS Market

Source: Annual Reports, SEC Filings, Investor Presentations, Press Releases, Journals, Articles, ClinicalTrials.gov, the World Bank, International Federation of Pharmaceutical Manufacturers & Associations, U.S. Food and Drug Administration, National Institutes of Health, the EU Industrial R&D Investment Scoreboard, Expert Interviews, and MarketsandMarkets Analysis

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Healthcare IT Markets on KnowledgeStore
Request Demo